Session Themes

How To Engage Community Oncologists in Precision Medicine   Session Co-Chairs: Lincoln Nadauld, Intermountain Health Care; Laurence Marton, PMWC 2014 Program Chair

How To Engage Community Oncologists in Precision Medicine

Session Co-Chairs: Lincoln Nadauld, Intermountain Health Care; Laurence Marton, PMWC 2014 Program Chair

Companion Diagnostics: Where is the Incentive?   Session Chair: Ed Winnick, GenomeWeb

Companion Diagnostics: Where is the Incentive?

Session Chair: Ed Winnick, GenomeWeb

Immunotherapy: Emerging Applications and Therapies    Session Chair: James Allison, MD Anderson Cancer Center

Immunotherapy: Emerging Applications and Therapies

Session Chair: James Allison, MD Anderson Cancer Center

Integrating Precision Medicine: Technical Challenges and Solutions   Session Chair: Eric Dishman, NIH

Integrating Precision Medicine: Technical Challenges and Solutions

Session Chair: Eric Dishman, NIH

The Economics of Bringing Precision Medicine to the Clinic   Session Chair: George Poste, ASU

The Economics of Bringing Precision Medicine to the Clinic

Session Chair: George Poste, ASU

Genetic Testing In Healthy Population   Session Chair: Randy Scott, Invitae

Genetic Testing In Healthy Population

Session Chair: Randy Scott, Invitae

The Secret to Wellness is Science   Session Chair: Lee Hood, Providence Health

The Secret to Wellness is Science

Session Chair: Lee Hood, Providence Health

Human Biospecimen Acquisition; Risks, Challenges and Solutions   Session Chair: Matt McLoughlin, Scientist.com

Human Biospecimen Acquisition; Risks, Challenges and Solutions

Session Chair: Matt McLoughlin, Scientist.com

ME/CFS: The Mysterious Illness Science Has Yet to Unravel   Session Chair: Zaher Nahle, Solve ME/CFS Initiative

ME/CFS: The Mysterious Illness Science Has Yet to Unravel

Session Chair: Zaher Nahle, Solve ME/CFS Initiative

Adoption of Precision Medicine:  Hereditary Cancer   Session Chair: Taylor Sittler, Color Genomics

Adoption of Precision Medicine: Hereditary Cancer

Session Chair: Taylor Sittler, Color Genomics

CIAPM: Accelerating Precision Medicine Advances in California   Session Chair: Elizabeth Baca, Governor’s Office of Planning and Research; Uta Grieshammer, CIAPM

CIAPM: Accelerating Precision Medicine Advances in California

Session Chair: Elizabeth Baca, Governor’s Office of Planning and Research; Uta Grieshammer, CIAPM

CRISPR Technology – How It Has Changed Biological Research   Session Chair: Shawn Shafer, MilliporeSigma

CRISPR Technology – How It Has Changed Biological Research

Session Chair: Shawn Shafer, MilliporeSigma

How to Commercialize Disruptive Technologies That Advance Precision Medicine   Session Chair: Alex De Winter, GE Ventures

How to Commercialize Disruptive Technologies That Advance Precision Medicine

Session Chair: Alex De Winter, GE Ventures

Let’s talk mHealth And Telehealth And Their Impact On Our Lives   Session Chair: Ida Sim, UCSF

Let’s talk mHealth And Telehealth And Their Impact On Our Lives

Session Chair: Ida Sim, UCSF

Tumor Profiling to Clinical Action   Session Chair: Wolfgang Daum, Toma Biosciences

Tumor Profiling to Clinical Action

Session Chair: Wolfgang Daum, Toma Biosciences

Scaling the 26-Hour Genome   Session Chair: Pieter van Rooyen, Edico Genome

Scaling the 26-Hour Genome

Session Chair: Pieter van Rooyen, Edico Genome

Patient Power: The Changing Role of Individuals   Session Chair: Cliff Reid, Genos Research

Patient Power: The Changing Role of Individuals

Session Chair: Cliff Reid, Genos Research

Progress in Improving the Evidence Base and Insurer Coverage   Session Chair: Kathryn Phillips, UCSF

Progress in Improving the Evidence Base and Insurer Coverage

Session Chair: Kathryn Phillips, UCSF

Medical Devices and IoT: the Bridge to the Phenotype   Session Chair: Sanjay Joshi, Dell EMC

Medical Devices and IoT: the Bridge to the Phenotype

Session Chair: Sanjay Joshi, Dell EMC

An Update on the Cancer Moonshot Blood Profiling Atlas   Session Chair: Bruce Press, Seven Bridges

An Update on the Cancer Moonshot Blood Profiling Atlas

Session Chair: Bruce Press, Seven Bridges

An Update on the Cancer Moonshot and Brain Government Initiatives   Session Chair: Joshua Gordon, National Institute of Mental Health

An Update on the Cancer Moonshot and Brain Government Initiatives

Session Chair: Joshua Gordon, National Institute of Mental Health

Data Sharing: Patient Rights and Privacy   Session Chair: William Knox Carey, Genecloud

Data Sharing: Patient Rights and Privacy

Session Chair: William Knox Carey, Genecloud

Enabling Advances in Human Microbiome Research   Session Chair: Nick Conley, Epibiome

Enabling Advances in Human Microbiome Research

Session Chair: Nick Conley, Epibiome

Biobanking Your Future   Session Chair: Nazneen Aziz, Kaiser Permanente

Biobanking Your Future

Session Chair: Nazneen Aziz, Kaiser Permanente

Health Systems as Translational Research Partners    Session Chair: Walter “Buzz” Stewart, Sutter Health

Health Systems as Translational Research Partners

Session Chair: Walter “Buzz” Stewart, Sutter Health

How Molecular Subtyping Can Aid Clinical Drug Development   Session Chair: Janusz Dutkowski, Data4Cure

How Molecular Subtyping Can Aid Clinical Drug Development

Session Chair: Janusz Dutkowski, Data4Cure

Precision Measurement in Biology    Session Chair: Stephen Quake, Stanford University

Precision Measurement in Biology

Session Chair: Stephen Quake, Stanford University

NGS: Implementing a Clinical Workflow for All Constituents   Session Chair: Matthew Tindall, Omicia

NGS: Implementing a Clinical Workflow for All Constituents

Session Chair: Matthew Tindall, Omicia

How Scientific Wellness Will Transform Healthcare   Session Chair: Lee Hood, Providence Health

How Scientific Wellness Will Transform Healthcare

Session Chair: Lee Hood, Providence Health

Understanding Human Health and Diseases at the Individual Level   Session Chair: Euan Ashley, Stanford Clinical Genomics Service

Understanding Human Health and Diseases at the Individual Level

Session Chair: Euan Ashley, Stanford Clinical Genomics Service

Learnings from Precision Medicine Centers   Session Chair: Berta Strulovici, Weizmann Institute

Learnings from Precision Medicine Centers

Session Chair: Berta Strulovici, Weizmann Institute

How to Make Rx-Dx Alliances Work   Session Chair: Myla Lai-Goldman, GeneCentric; Eric Lai, Takeda

How to Make Rx-Dx Alliances Work

Session Chair: Myla Lai-Goldman, GeneCentric; Eric Lai, Takeda

The Value of Data Sharing   Session Chair: John Leite, Illumina; John Shon, Illumina

The Value of Data Sharing

Session Chair: John Leite, Illumina; John Shon, Illumina

Population Precision Medicine   Session Chair: Kirsten Bibbins-Domingo, UCSF

Population Precision Medicine

Session Chair: Kirsten Bibbins-Domingo, UCSF

Bringing Liquid Biopsy to the Clinic: Overcoming Fundamental Challenges   Session Chair: Walter Koch, Roche

Bringing Liquid Biopsy to the Clinic: Overcoming Fundamental Challenges

Session Chair: Walter Koch, Roche

Personalized Medicine – The Cinderella Story of Venture Investments?   Session Chair: Mara Aspinall, Genepeeks

Personalized Medicine – The Cinderella Story of Venture Investments?

Session Chair: Mara Aspinall, Genepeeks

How Immuno-oncology Saved My Life: A Patient’s Perspective   Session Chair: Andrew Schorr, Patient Power

How Immuno-oncology Saved My Life: A Patient’s Perspective

Session Chair: Andrew Schorr, Patient Power

Developing Successful Predictive Clinical Biomarkers   Session Chair: Ann Kapoun, Oncomed

Developing Successful Predictive Clinical Biomarkers

Session Chair: Ann Kapoun, Oncomed

Achieving Accurate NGS Test Results   Session Chair: Russell Garlick, SeraCare

Achieving Accurate NGS Test Results

Session Chair: Russell Garlick, SeraCare

Clinical Trials in Immunotherapy   Session Chair: Patrice Hugo, Q2 Solutions

Clinical Trials in Immunotherapy

Session Chair: Patrice Hugo, Q2 Solutions

Predictive Biomarkers and Companion Diagnostics for Immuno-Oncology   Session Chair: Brad Gray, NanoString Technologies

Predictive Biomarkers and Companion Diagnostics for Immuno-Oncology

Session Chair: Brad Gray, NanoString Technologies

Generating Insights from Multi-modal Healthcare Data for Precision Medicine   Session Chair: Atul Butte, UCSF

Generating Insights from Multi-modal Healthcare Data for Precision Medicine

Session Chair: Atul Butte, UCSF

Issues and Challenges of Immunotherapy   Session Chair: Larry Corey, Fred Hutchinson Cancer Research Center

Issues and Challenges of Immunotherapy

Session Chair: Larry Corey, Fred Hutchinson Cancer Research Center

The Last Clinical Mile of Precision Medicine – Challenges at the Point of Care   Session Chair: Assaf Halevy, 2bPrecise

The Last Clinical Mile of Precision Medicine – Challenges at the Point of Care

Session Chair: Assaf Halevy, 2bPrecise

Implementing Precision Medicine Programs: Real-world Solutions to Practical Challenges   Session Chair: Chris Cournoyer, N-of-One

Implementing Precision Medicine Programs: Real-world Solutions to Practical Challenges

Session Chair: Chris Cournoyer, N-of-One

Emerging Technologies Hold Promise to Inform the Practice of Precision Medicine   Session Chair: John Ryals, Metabolon

Emerging Technologies Hold Promise to Inform the Practice of Precision Medicine

Session Chair: John Ryals, Metabolon

Unlocking Real-World Clinical Data   Session Chair: Amy Abernethy, Flatiron Health

Unlocking Real-World Clinical Data

Session Chair: Amy Abernethy, Flatiron Health

Immunotherapy: Immunocheckpoint Inhibitors & Beyond   Session Chair: Irv Weissman, Stanford School of Medicine

Immunotherapy: Immunocheckpoint Inhibitors & Beyond

Session Chair: Irv Weissman, Stanford School of Medicine

Emerging Themes in the Human Microbiome   Session Chair: Michael Fischbach, UCSF

Emerging Themes in the Human Microbiome

Session Chair: Michael Fischbach, UCSF

Expanding the Reach of Genomic Analysis   Session Chair: Deanna Church, 10x Genomics

Expanding the Reach of Genomic Analysis

Session Chair: Deanna Church, 10x Genomics

Precision Medicine Patent Law Update   Session Chairs: Catherine Polizzi, Morrison and Foerster and Michael Shuster, Fenwick & West

Precision Medicine Patent Law Update

Session Chairs: Catherine Polizzi, Morrison and Foerster and Michael Shuster, Fenwick & West

New Healthcare Paradigm from the $100 Genome   Session Chair:  Yiwu He, BGI

New Healthcare Paradigm from the $100 Genome

Session Chair: Yiwu He, BGI

Beyond Genomics for Predicting Patient Response   Session Chair: Parker Cassidy, Mitra Biotech

Beyond Genomics for Predicting Patient Response

Session Chair: Parker Cassidy, Mitra Biotech

Building Value for Liquid Biopsies in Oncology   Session Chair: Frederic Pla, Genomic Health

Building Value for Liquid Biopsies in Oncology

Session Chair: Frederic Pla, Genomic Health

Large Scale Human Genetics in Genomic Medicine and Drug Discovery   Session Chair: Aris Baras, Regeneron

Large Scale Human Genetics in Genomic Medicine and Drug Discovery

Session Chair: Aris Baras, Regeneron

Rare Disease Drug Development in Precision Medicine   Session Chair: Mary Dixon Drake, Innovenn

Rare Disease Drug Development in Precision Medicine

Session Chair: Mary Dixon Drake, Innovenn

Clinical Next-Gen Sequencing for Infectious Disease Diagnosis   Session Chair: Charles Chiu, UCSF

Clinical Next-Gen Sequencing for Infectious Disease Diagnosis

Session Chair: Charles Chiu, UCSF

Diagnostics Policy and the Impact on Innovation   Session Chair: Michael W. Nall, Biocept

Diagnostics Policy and the Impact on Innovation

Session Chair: Michael W. Nall, Biocept

Pathogen Specific Biologics for Infectious Diseases   Session Chair: Steven J. Projan, Medimmune

Pathogen Specific Biologics for Infectious Diseases

Session Chair: Steven J. Projan, Medimmune

Importance of Standardized Assays for Precision Medicine   Session Chair: Jeffrey Edward Miller, Invivoscribe

Importance of Standardized Assays for Precision Medicine

Session Chair: Jeffrey Edward Miller, Invivoscribe

Complementary Use of Digital PCR and NGS in Cancer Liquid Biopsy   Session Chair: George Karlin-Neumann, BioRad

Complementary Use of Digital PCR and NGS in Cancer Liquid Biopsy

Session Chair: George Karlin-Neumann, BioRad

Moving Precision Medicine to Precision Health   Session Chair: Harold L. Paz, Aetna

Moving Precision Medicine to Precision Health

Session Chair: Harold L. Paz, Aetna

Clinical Applications of ctDNA in Cancer Management   Session Chair: Clive Morris, Inivata

Clinical Applications of ctDNA in Cancer Management

Session Chair: Clive Morris, Inivata

Next-Generation Liquid Biopsy Testing: Promise and Limitations   Session Chair: Jason Myers, ArcherDX

Next-Generation Liquid Biopsy Testing: Promise and Limitations

Session Chair: Jason Myers, ArcherDX

Emerging Infections: Tracking, Testing and Public Health Response   Session Chair: Steve Miller, UCSF

Emerging Infections: Tracking, Testing and Public Health Response

Session Chair: Steve Miller, UCSF

Advancing the Clinic with Emerging NGS Technologies   Session Chair: Allison Ballmer, Roche

Advancing the Clinic with Emerging NGS Technologies

Session Chair: Allison Ballmer, Roche